No influence of imatinib on type 2 diabetes
Chodorowski, Z.; Sein Anand, J.; Hellmann, A.; Prejzner, W.
Przeglad Lekarski 64(4-5): 370-371
2007
ISSN/ISBN: 0033-2240 PMID: 17724918 Document Number: 614469
Five patients with type 2 diabetes, three of them treated with insulin and two with oral antidiabetic drugs, receiving imatinib due to chronic myeolid leukaemia are reported. Treatment with imatinib 400 mg/day for 7 to 37 (mean 24.2) months had no positive effect on clinical course of type 2 diabetes.
Document emailed within 1 workday
Related Documents
Zasimowicz, E.; Wolszczak, B.; Zasimowicz, B. 2014: Influence of ethyl alcohol on diabetes pathogenesis type Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(213): 212-214Juntti-Berggren, L.; Pigon, J.; Hellström, P.; Holst, J.J.; Efendic, S. 2000: Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes Diabetes Nutrition and Metabolism 13(1): 7-12
Wiczyńska-Zajac, A.; Bomba-Opoń, D.A.; Domańska-Janczewska, E.; Jóźwicka, E.; Marianowski, L. 2000: The influence of prenatal glucocorticoids on glycemic control among pregnant women with type i diabetes Ginekologia Polska 71(8): 900-905
Mosbah, A.A.A.E.-R.; Abd-Ellatif, N.A.B.; Sorour, E.I. 2011: Influence of serum cortisol levels on glycemic control in children with type 1 diabetes Journal of the Egyptian Society of Parasitology 41(3): 777-784
Wadström, J.; Gannedahl, G.; Wahlberg, J.; Frödin, L.; Tedbrandt, A.; Berne, C. 1994: Development of type Ii diabetes after combined kidney-pancreas transplantation in a patient with type i (insulin-dependent) diabetes Transplantation Proceedings 26(3): 1761-1762
Skripchenko, N.D.; Sharafetdinov, K.K.; Plotnikova, O.A.; Meshcheriakova, V.A. 2002: Influence of caloric restriction diet on clinical and biochemical parameters in patients with type 2 diabetes mellitus Voprosy Pitaniia 71(4): 13-17
Sharonova, L.a.; Verbovoj, A.e.; Canava, L.a.; Verbovaja, N. 2016: The Influence of Adiponectin and Leptin Levels on Myocardial Remodeling in Patients with type 2 Diabetes Mellitus and Gout Klinicheskaia Meditsina 94(2): 120-127
De Sanctis, V. 2018: Type 1 and Type 2 diabetes in children and adolescents: a public health problem in Qatar. The experience of Pediatric Diabetes Center at Hamad General Hospital (HGH) of Doha Acta Bio-Medica: Atenei Parmensis 89(S5): 5-6
Shi, R.; Lin, J.; Guo, Y.; Gong, Y.P. 2014: The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib-resistant K562R leukemia cells Die Pharmazie 69(5): 346-352
Davì, G.; Belvedere, M.; Vigneri, S.; Catalano, I.; Giammarresi, C.; Roccaforte, S.; Consoli, A.; Mezzetti, A. 1996: Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus Thrombosis and Haemostasis 76(1): 34-37
Bogdanski, P.; Pupek-Musialik, D.; Dytfeld, J.; Jagodzinski, P.P.; Jablecka, A.; Kujawa, A.; Musialik, K. 2007: Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus International Journal of Clinical Pharmacology and Therapeutics 45(10): 563-567
De Luis, D.A.; Gonzalez Sagrado, M.; Aller, R.; Izaola, O.; Conde, R.; De la Fuente, B. 2010: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2 European Review for Medical and Pharmacological Sciences 14(2): 89-95
Zhong, X.; Tanasugarn, C.; Fisher, E.B.; Krudsood, S.; Nityasuddhi, D. 2011: Awareness and practices of self-management and influence factors among individuals with type 2 diabetes in urban community settings in Anhui Province, China Southeast Asian Journal of Tropical Medicine and Public Health 42(1): 185-186; 184 187-196
DZugkoev, S.G.; Zangieva, O.D.; Dzugkoeva, F.S. 2013: Influence of combined treatment on biochemical and functional characteristics in patients with vascular complications of type 1 diabetes mellitus and different pathways of compensation Klinicheskaia Meditsina 91(2): 14-18
Mizrahi, E.; Liberty, I.; Tsedek, I.; Harari, M.; Friger, M.; Sukenik, S. 2011: The influence of single immersion in Dead Sea water on glucose, insulin, cortisol and C-peptide levels in type 2 diabetes mellitus patients Harefuah 150(8): 646-649; 689, 688
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89
Likitmaskul, S.; Wacharasindhu, S.; Rawdaree, P.; Ngarmukos, C.; Deerochanawong, C.; Suwanwalaikorn, S.; Chetthakul, T.; Bunnag, P.; Kosachunhanun, N.; Plengvidhaya, N.; Leelawatana, R.; Krittiyawong, S.; Benjasuratwong, Y.; Pratipanawatr, T. 2006: Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes Journal of the Medical Association of Thailand 89(Suppl 1): S10-S16
Sharafetdinov, K.Kh.; Gapparov, M.M.; Plotnikova, O.A.; Zykina, V.V.; Shlelenko, L.A.; Tiurina, O.E.; Rabotkin, I.V. 2009: Influence of breads with use of barley, buckwheat and oat flours and barley flakes on postprandial glycaemia in patients with type 2 diabetes mellitus Voprosy Pitaniia 78(4): 40-46
Sypalo, A.; Kravchun, P.; Kadykova, O. 2017: The Influence of Mono- and Multivascular Lesions of Coronary Arteries on the Course of Coronary Heart Disease in Patients with Diabetes Mellitus type 2 Georgian Medical News 264: 61-65
Scheinfeld, N. 2006: Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate Journal of Drugs in Dermatology: Jdd 5(3): 228-231